Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock?
Despite the recent earnings miss, Hologic's portfolio strength and capital allocation strategy can be appealing to investors.
Hologic Q4 Earnings Lag, Revenues Top, Stock Down in Aftermarket
HOLX's fiscal 2024 fourth-quarter results underscore the durable growth of its businesses.
Hologic, Inc. (HOLX) Q4 2024 Earnings Call Transcript
Hologic, Inc. (NASDAQ:HOLX ) Q4 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President & Chief Executive Officer Essex Mitchell - Chief Operating Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Anthony Petrone - Mizuho Group Vijay Kumar - Evercore ISI Casey Woodring - JPMorgan Mike Matson - Needham & Company Navann Ty - BNP Paribas Ricardo Moreno - RBC Capital Markets Maggie Wilmouth - William Blair Andrew Cooper - Raymond James Operator Good afternoon, and welcome to the Hologic's Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Shelly, and I am your operator for today's call.
Hologic (HOLX) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Hologic (HOLX) Q4 Earnings Miss Estimates
Hologic (HOLX) came out with quarterly earnings of $1.01 per share, missing the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.89 per share a year ago.
Unlocking Q4 Potential of Hologic (HOLX): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Hologic (HOLX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Hologic (HOLX) closed at $80.46, marking a -0.46% move from the previous day.
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Non-COVID-19 Diagnostics Sales Drive Hologic's Q4 Earnings?
HOLX's fiscal 2024 fourth-quarter results are expected to reflect a solid performance of the Diagnostics business, led by the base Molecular franchise.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
